Medical specialists from France tagged as investigators in clinical trials studying Renal Cell Carcinoma
Total 134 results
-
Nathalie BONNIN, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud - Department of Medical Oncology
- Pierre-Bénite, Service de Médecine du vieillissement, Centre Hospitalier Lyon Sud (Hospices Civils de Lyon)
Trials:- NCT03296150 (Sub-Investigator)
- NCT04605146 (Sub-Investigator)
Conditions: -
Nathalie FREYMOND, MDSeen in:
- Pierre-Bénite, Hôpital Lyon Sud - Department of pneumology,Thoracic oncology
Trials:- NCT04605146 (Sub-Investigator)
Conditions: -
Nathalie MESGOUEZ-NEBOUT, MDSeen in:
- Angers, Institut de Cancérologie de l'Ouest
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Nicolas LESCUT, MDSeen in:
- Dijon, Institut de cancérologie de Bourgogne (Dijon, Auxerre, Chalon sur Saône)
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Nicolas MAGNE, MDSeen in:
- Saint-Étienne, Institut de cancérologie de la Loire Lucien Neuwirth
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Nicolas MOTTET, MD PhDSeen in:
- Saint-Étienne, CHU Saint-Etienne
Trials:- NCT04053855 (Principal Investigator)
Conditions: -
Olivier HUILLARD, MD, PhDSeen in:
- Paris, Hôpital Cochin - AP-HP
Trials:- NCT05285579 (Principal Investigator)
Conditions: -
Pauline GILLON, MDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Pierre AUBERDIAC, MDSeen in:
- Albi, Clinique Claude Bernard
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Pierre Graff-Cailleaud, MDSeen in:
- Toulouse, IUCT
- Toulouse, Institut Claudius Regaud
Trials:- NCT03830788 (Principal Investigator)
- NCT04299646 (Principal Investigator)
Conditions: -
Pierre Jean SOUQUET, MDSeen in:
- Pierre-Bénite, Hôpital Lyon Sud - Department of pneumology,Thoracic oncology
Trials:- NCT04605146 (Principal Investigator)
Conditions: -
Pierre Laurent-Puig, MD, PhDSeen in:
- Paris, AP-HP European Georges Pompidou Hospital
Trials:- NCT03149523 (Principal Investigator)
Conditions: -
Pierre-Alexis AUTRUSSEAU, MDSeen in:
- Strasbourg, Service d'Imagerie Interventionnelle - CHU de Strasbourg - France
Trials:- NCT05461027 (Principal Investigator)
Conditions: -
Pierre-Emmanuel BRACHET, MDSeen in:
- Caen, Centre Francois Baclesse
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Remy DELVA, MDSeen in:
- Angers, Ico - Paul Papin
Trials:- NCT05096390 (Principal Investigator)
Conditions: -
René Jean BENSADOUN, PhDSeen in:
- Nice, Centre Haute Energie
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Samar Line KRHLI, MDSeen in:
- Paris, Institut Curie
Trials:- NCT04299646 (Principal Investigator)
Conditions: -
Sébastien COURAUD, MDSeen in:
- Pierre-Bénite, Hôpital Lyon Sud - Department of pneumology,Thoracic oncology
Trials:- NCT04605146 (Sub-Investigator)
Conditions: -
Sigolène Galland-Girodet, MDSeen in:
- Bordeaux, Radiothérapie Bordeaux Nord Aquitaine
- Cedex, Bordeaux, Polyclinique Bordeaux Nord
Trials:- NCT01817192 (Principal Investigator)
- NCT04299646 (Principal Investigator)
-
Slimane DERMECHE, MDSeen in:
- Lyon, Centre Léon Berard
Trials:- NCT04299646 (Sub-Investigator)
Conditions: -
Sophie ABADIE-LACOURTOISIE, MDSeen in:
- Angers, Institut de Cancérologie de l'Ouest
Trials:- NCT04764487 (Principal Investigator)
Conditions: -
Sophie Cousin, MDSeen in:
- Bordeaux Cedex, Institut Bergonie
- Bordeaux, EDOG - Institut Bergonie - PPDS
- Bordeaux, Institut Bergonie
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05403385 (Principal Investigator)
- NCT04880382 (Principal Investigator)
- NCT03475953 (Principal Investigator)
- NCT05668585 (Principal Investigator)
- NCT05027867 (Principal Investigator)
Conditions:- Metastatic NSCLC;
- Stage III NSCLC;
- Non Small Cell Lung Cancer;
- Hepatocellular Carcinoma;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Soft-tissue Sarcoma;
- Urothelial Carcinoma;
- Thyroid Cancer;
- Gastro-enteropancreatic Neuroendocrine Tumor;
- Biliary Tract Cancer;
- HPV-Related Carcinoma;
- Solid Tumor, Adult;
- Mesotheliomas Pleural;
- GIST;
- Renal Carcinoma;
- Colorectal Cancer Not MSI-H or MMR-deficient;
- Oesophageal or Gastric Carcinoma;
- Melanoma;
- NSCLC;
- Solid Tumors;
- CRC;
- ATC;
- Small Cell Lung Carcinoma;
- Small-cell Lung Cancer;
- Small Cell Lung Cancer Extensive Stage;
- Small Cell Lung Cancer Recurrent
-
Sophie DUPLOMB, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud - Department of Medical Oncology
Trials:- NCT04605146 (Sub-Investigator)
Conditions: -
Sophie TARTAS, MDSeen in:
- Pierre-Bénite, Centre Hospitalier Lyon Sud - Department of Medical Oncology
- Pierre-Bénite, Service de Médecine du vieillissement, Centre Hospitalier Lyon Sud (Hospices Civils de Lyon)
Trials:- NCT03296150 (Sub-Investigator)
- NCT04605146 (Sub-Investigator)
Conditions: -
Stéphane DALLE, MDSeen in:
- Pierre-Bénite, Hôpital Lyon Sud - Department of Dermatology, HCL-Cancer Institute
Trials:- NCT04605146 (Principal Investigator)
Conditions: -
Stéphane Oudard, MD, PhDSeen in:
- Paris, AP-HP European Georges Pompidou Hospital
- Paris, AP-HP Hôpital Européen Georges Pompidou
Trials:- NCT03149523 (Sub-Investigator)
- NCT05096390 (Principal Investigator)
-
Stéphane Supiot, MDSeen in:
- Nantes, Institut de Cancérologie de l'Ouest
- Saint-Herblain, Institut de Cancérologie de l'Ouest - Site Gauducheau
Trials:- NCT03830788 (Principal Investigator)
- NCT04299646 (Principal Investigator)
Conditions: -
STORY FleurSeen in:
- Strasbourg, Les Hôpitaux Universitaires de Strasbourg
Trials:- NCT04946266 (Sub-Investigator)
Conditions: -
Sylvie NEGRIERSeen in:
- Lyon, Centre Léon Berard
Trials:- NCT05096390 (Principal Investigator)
Conditions:
Clinical Trials on Renal Cell Carcinoma
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Unresectable Renal Cell... and other conditionsUnited States
-
Australian and New Zealand Urogenital and Prostate...RecruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11.2 Translocation-Related Renal Cell CarcinomaAustralia
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell CarcinomaUnited States
-
Osel, Inc.National Cancer Institute (NCI); City of Hope Medical Center; Miyarisan Pharmaceuticals...RecruitingMetastatic Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Sarcomatoid Renal Cell Carcinoma | Advanced Renal Cell Carcinoma | Advanced Sarcomatoid Renal...United States
-
National Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States, Taiwan, Australia
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingChromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma | Fumarate Hydratase Deficient Renal Cell Carcinoma | Succinate Dehydrogenase Deficient Renal Cell Carcinoma | Collecting Duct Renal...United States
-
Jonsson Comprehensive Cancer CenterBeiGene; Driven To CureWithdrawnMetastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Unresectable Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Clear Cell Papillary Renal Neoplasm | Hereditary Papillary Renal Cell Carcinoma and other conditionsUnited States
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers SquibbActive, not recruitingRenal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Papillary Renal Cell Carcinoma Type 1 | Papillary Renal Cell Carcinoma Type 2 | Chromophobe Renal Cell Carcinoma | Xp11 Translocation CarcinomaAustralia
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada